Tacita Capital’s Pfizer PFE Stock Holding History

Tacita Capital’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$59.6K	Hold	2,476	–	–	0.03%	132
2026 Q1	$69.5K	Hold	2,476	–	–	0.04%	125
2025 Q4	$61.7K	Sell	2,476 -279	-10%	-$7.04K	0.04%	132
2025 Q3	$70.2K	Hold	2,755	–	–	0.04%	123
2025 Q2	$66.8K	Buy	2,755 +1,800	+188%	+$42K	0.04%	119
2025 Q1	$24.2K	Hold	955	–	–	0.02%	168
2024 Q4	$25.3K	Hold	955	–	–	0.02%	164
2024 Q3	$27.6K	Hold	955	–	–	0.02%	156
2024 Q2	$26.7K	Hold	955	–	–	0.02%	165
2024 Q1	$26.5K	Hold	955	–	–	0.02%	167
2023 Q4	$27.5K	Hold	955	–	–	0.02%	167
2023 Q3	$31.7K	Sell	955 -750	-44%	-$26.5K	0.02%	159
2023 Q2	$63K	Hold	1,705	–	–	0.05%	125
2023 Q1	$70K	Buy	1,705 +750	+79%	+$32.4K	0.05%	111
2022 Q4	$49K	Sell	955 -120	-11%	-$5.75K	0.04%	134
2022 Q3	$47K	Hold	1,075	–	–	0.04%	124
2022 Q2	$56K	Hold	1,075	–	–	0.04%	124
2022 Q1	$56K	Hold	1,075	–	–	0.03%	136
2021 Q4	$63K	Buy	+1,075	New	+$53.3K	0.04%	123

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Tacita Capital's PFE Position: Q2 2026 in Review

Tacita Capital held its Pfizer (PFE) position steady in Q2 2026 at 2,476 shares worth $59.6K. The position accounts for 0.03% of the portfolio, ranked #132.

Tacita Capital first reported a position in PFE in Q4 2021 and has held it in 19 quarters since. The position peaked at $70.2K in Q3 2025. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Tacita Capital held 2,476 shares of Pfizer worth $59.6K as of Q2 2026.
Tacita Capital left its Pfizer share count unchanged in Q2 2026.
Pfizer made up 0.03% of Tacita Capital's portfolio in Q2 2026, its #132 holding.
Tacita Capital first reported a position in Pfizer in Q4 2021 and has held it in 19 quarters since.
Tacita Capital's Pfizer position peaked at $70.2K in Q3 2025.
2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Tacita Capital's 13F filing for Q2 2026, filed 10 Aug 2026.